Press release
Anus Neoplasms Treatment Market Size Report 2032 | Inovio Pharmaceuticals, Merck Sharp & Dohme LLC, Advaxis, Oryx GmbH & Co. KG, Frantz Viral Therapeutics, LLC, Incyte Corporation, Sumitomo Pharma America, Inc
Anus Neoplasms Market
Discover Key Insights into the Anus Neoplasms Market with DelveInsight's In-Depth Report @ Anus Neoplasms Market Size- https://www.delveinsight.com/sample-request/anus-neoplasms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Anus Neoplasms Market Report
• In February 2025, Sumitomo Pharma America, Inc. initiated an open-label, Phase I dose escalation and Phase II dose expansion study to assess the safety, tolerability, and preliminary antitumor activity of SMP 3124LP in adults with advanced solid tumors.
• In February 2025, UNICANCER launched an interventional study evaluating the efficacy of immunotherapy (pembrolizumab) in combination with targeted therapy (vorinostat) in patients with recurrent and/or metastatic squamous cell carcinoma, including head and neck, lung, cervix, anus.
• In February 2025, Transgene commenced a Phase Ib/II trial evaluating the combination of TG4001 and Avelumab in patients with HPV-16 positive recurrent or metastatic malignancies.
• In February 2025, MacroGenics initiated Study CP-MGC018-03, an open-label, two-part, Phase II study. Part 1 of the study will enroll participants with metastatic castration-resistant prostate cancer (mCRPC) who have been previously treated with one prior androgen receptor axis-targeted therapy (ARAT), including abiraterone, enzalutamide, or apalutamide.
• In February 2025, the SOLTI Breast Cancer Research Group launched an open-label, parallel-group, non-randomized, multicenter Phase II study to evaluate the efficacy of spartalizumab (cohorts 1 and 2) and tislelizumab (cohort 3) as monotherapy in patients with PD1-high-expressing tumors.
• The leading Anus Neoplasms Companies such as Inovio Pharmaceuticals, Merck Sharp & Dohme LLC, Advaxis, Oryx GmbH & Co. KG, Frantz Viral Therapeutics, LLC, Incyte Corporation, Sumitomo Pharma America, Inc. and others.
• Promising Anus Neoplasms Therapies such as VGX-3100, Pembrolizumab, Paclitaxel, Carboplatin, Cetuximab, Fluorouracil, MPDL3280A and others.
Stay ahead in the Anus Neoplasms Therapeutics Market with DelveInsight's Strategic Report @ Anus Neoplasms Market Outlook- https://www.delveinsight.com/sample-request/anus-neoplasms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Anus Neoplasms Epidemiology Insights
The epidemiology section of Anus Neoplasms offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Anus Neoplasms Epidemiology trends @ Anus Neoplasms Prevalence- https://www.delveinsight.com/sample-request/anus-neoplasms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Anus Neoplasms Drugs Market
The Anus Neoplasms Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Anus Neoplasms signaling in Anus Neoplasms are likely to uncover new therapeutic targets and further expand treatment options for patients.
Anus Neoplasms Treatment Market Landscape
The Anus Neoplasms treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Anus Neoplasms has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about Anus Neoplasms treatment guidelines, visit @ Anus Neoplasms Treatment Market Landscape- https://www.delveinsight.com/sample-request/anus-neoplasms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Anus Neoplasms Market Outlook
The report's outlook on the Anus Neoplasms market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Anus Neoplasms therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Anus Neoplasms drug and late-stage pipeline therapy.
Anus Neoplasms Drugs Uptake
The drug chapter of the Anus Neoplasms report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Anus Neoplasms.
Major Anus Neoplasms Companies
Inovio Pharmaceuticals, Merck Sharp & Dohme LLC, Advaxis, Oryx GmbH & Co. KG, Frantz Viral Therapeutics, LLC, Incyte Corporation, Sumitomo Pharma America, Inc. and others.
Learn more about the FDA-approved drugs for Anus Neoplasms @ Drugs for Anus Neoplasms Treatment- https://www.delveinsight.com/sample-request/anus-neoplasms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Anus Neoplasms Market Report
• Coverage- 7MM
• Anus Neoplasms Companies- Inovio Pharmaceuticals, Merck Sharp & Dohme LLC, Advaxis, Oryx GmbH & Co. KG, Frantz Viral Therapeutics, LLC, Incyte Corporation, Sumitomo Pharma America, Inc. and others.
• Anus Neoplasms Therapies- VGX-3100, Pembrolizumab, Paclitaxel, Carboplatin, Cetuximab, Fluorouracil, MPDL3280A and others.
• Anus Neoplasms Market Dynamics: Anus Neoplasms Market Drivers and Barriers
• Anus Neoplasms Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Anus Neoplasms Drugs in development @ Anus Neoplasms Clinical Trials Assessment- https://www.delveinsight.com/sample-request/anus-neoplasms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Report Introduction
3. Anus Neoplasms Market Overview at a Glance
4. Executive Summary of Anus Neoplasms
5. Key Events
6. Epidemiology and Market Methodology
7. Disease Background and Overview
8. Epidemiology and Patient Population
9. Patient Journey
10. Marketed Therapies
11. Emerging Therapies
12. Anus Neoplasms: Market Analysis
13. KOL Views
14. SWOT Analysis
15. Unmet Needs
16. Market Access
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight
List of Top Selling Market Research Reports in 2025
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-market
Urea cycle disorders market- https://www.delveinsight.com/blog/urea-cycle-disorder-market
Overactive bladder syndrome market- https://www.delveinsight.com/report-store/underactive-bladder-market
Surgical energy instruments market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
Total knee arthroplasty market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Indwelling catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Surgical robotic system market- https://www.delveinsight.com/report-store/surgical-robotic-system-market
Surgical sealant market - https://www.delveinsight.com/report-store/surgical-sealant-and-adhesives-market
Novel drug delivery devices market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Healthcare competitive benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Ventral hernia market- https://www.delveinsight.com/report-store/hernia-repair-devices-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
Trichotillomania market- https://www.delveinsight.com/sample-request/trichotillomania-ttm-market
Medical marijuana market- https://www.delveinsight.com/blog/medical-marijuana-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anus Neoplasms Treatment Market Size Report 2032 | Inovio Pharmaceuticals, Merck Sharp & Dohme LLC, Advaxis, Oryx GmbH & Co. KG, Frantz Viral Therapeutics, LLC, Incyte Corporation, Sumitomo Pharma America, Inc here
News-ID: 3898099 • Views: …
More Releases from DelveInsight Business Research LLP
Burkitt Lymphoma Therapeutics Market Gains Momentum with Strong Pipeline and Imp …
(Albany, United States) The Burkitt lymphoma market is expected to experience significant growth across the seven major markets (7MM), which include the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. This growth is driven by several factors, including the increasing prevalence of the disease, advancements in diagnostic capabilities, and a strong pipeline of new therapies. Key Burkitt lymphoma companies, such as Jazz Pharmaceuticals, Xencor, ADC…
GLP-1 Agonists Redefining Diabetes and Obesity Treatment: New Approvals, Expandi …
(Albany, United States) The latest comprehensive report by DelveInsight delivers detailed insights into the current and forecasted GLP-1 market size across 7MM, covering the period from 2020 to 2034. The glucagon market has witnessed transformative growth in recent years as GLP-1 agonists continue to demonstrate exceptional efficacy in managing type 2 diabetes and weight-related conditions. Key GLP-1 companies driving the growth in this landscape include AstraZeneca, Pfizer, Boehringer Ingelheim, Eli…
Multiple Myeloma Market: FDA Approvals and Orphan Designations Accelerate Pipeli …
(Albany, United States) The multiple myeloma treatment paradigm is undergoing a dynamic evolution, marked by increasing therapeutic interventions by companies such as Sanofi, Karyopharm Therapeutics, AbbVie, Takeda Pharmaceutical, Celgene, BMS, RAPA Therapeutics, Pfizer, Array Biopharma, Cellectar Biosciences, BioLineRx, Celgene, Aduro Biotech, ExCellThera, Janssen Pharmaceutical, Precision BioSciences, Takeda, Glenmark, Poseida Therapeutics, Molecular Partners, Chipscreen Biosciences, Roche, Janssen, Nanjing Legend Biotech, Merck, and others.
DelveInsight's comprehensive report titled "Multiple Myeloma Market Insight, Epidemiology…
Breast Cancer Market to Surge in 7MM, Driven by Clinical Pipeline Advancements a …
(Albany, United States) The Breast Cancer market is undergoing significant expansion, driven by increasing disease prevalence and the introduction of innovative therapeutic options from companies such as Veru, Sanofi, Roche, AstraZeneca, Eli Lilly, EQRx, Gilead, Sermonix Pharmaceuticals, Evgen Pharma, Tyme, Genentech, and Daiichi Sankyo, among others.
DelveInsight's latest report, "Breast Cancer - Market Insight, Epidemiology and Market Forecast - 2032" (https://www.delveinsight.com/report-store/breast-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr) combines robust epidemiological data with market trends, competitive landscape analysis,…
More Releases for Anus
Anoscope Market Size, Trends, Growth, Outlook 2024-2033
The anoscope market size has grown strongly in recent years. It will grow from $13.96 billion in 2023 to $15 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to prevalence of anorectal disorders, aging population, growing patient awareness, growth of endoscopic procedures.
The anoscope market size is expected to see strong growth in the next few…
Anorectal Malformation Market is Expected to Show a Healthy Growth Rate During t …
DelveInsight's "Anorectal Malformation- Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Anorectal Malformation, historical and forecasted epidemiology as well as the Anorectal Malformation market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Download Sample Report to know more @ https://www.delveinsight.com/sample-request/anorectal-malformation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Anorectal Malformation Overview
Anorectal malformations comprise a wide spectrum of diseases, which can affect boys and girls, and involve the…
Anal Cancer Therapeutics Market Size, 2022 Analysis, Industry Trends and Forecas …
𝗧𝗵𝗲 𝗴𝗹𝗼𝗯𝗮𝗹 𝗔𝗻𝗮𝗹 𝗖𝗮𝗻𝗰𝗲𝗿 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝗶𝘀 𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝘁𝗼 𝗲𝘅𝗵𝗶𝗯𝗶𝘁 𝗮 𝗖𝗔𝗚𝗥 𝗼𝗳 6.5% 𝗼𝘃𝗲𝗿 𝘁𝗵𝗲 𝗳𝗼𝗿𝗲𝗰𝗮𝘀𝘁 𝗽𝗲𝗿𝗶𝗼𝗱 (2022-2030).
Global Anal Cancer Therapeutics Market 2022-2030, report discovers comprehensive insights on key manufacturers with share information, market size and projection, key dynamics, growth factors, and new company profiles. The report provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth in the coming years. Anal…
Global Anal Cancer Market Analysis - Industry Trends, Market Size, and Forecast …
Anal cancer is a cancer which arises from the anus, the distal opening of the gastrointestinal tract.Symptoms may include bleeding from the anus or a lump near the anus Other symptoms may include pain, itchiness, or discharge from the anus A change in bowel movements may also occur
Global Anal Cancer Market Report 2019 - Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the…
Anus Neoplasms Market: Smoking and HPV Infection to Keep the Market Intact
Timely treatment of anus tumors is often delayed as it mimics benign anal pathology. Though the treatment of the most prevalent anal tumor, squamous cell carcinoma, has not been evolved; the discovery of human papillomavirus infection has been the prominent etiology. Besides, melanoma, basal cell carcinoma and adenocarcinoma are other less prevalent neoplasms of the anal canal. These assimilations are according to the report titled “Anus Neoplasms Market,” which has…
Rectal Cancer Therapeutics Pipeline Review 2018 - Clinical Trials, Results, Grow …
Rectal cancer is a disease in which malignant (cancer) cells are formed in the tissues of the rectum. The rectum is the lower part of the colon that connects the large bowel to the anus. It starts at the end of the final segment of the colon and ends when it reaches the short, narrow passage leading to the anus. Adenocarcinomas or cancer in the epithelium, comprise the vast majority…
